Added to YB: 2025-08-13
Pitch date: 2025-08-11
FLGT [neutral]
Fulgent Genetics, Inc.
+3.19%
current return
Author Info
No bio for this author
Company Info
Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally.
Market Cap
$453.3M
Pitch Price
$20.68
Price Target
N/A
Dividend
N/A
EV/EBITDA
2.01
P/E
-6.65
EV/Sales
-0.46
Sector
Health Care Providers and Services
Category
growth
A Primer on Fulgent Genetics
FLGT (overview): Diagnostic & emerging therapeutic co. Lab biz offers comprehensive pathology & genetic testing; proprietary tech platform enables broad menu & rapid test dev. Therapeutic biz developing cancer nano-delivery platform w/ 2 candidates: FID-007 (Ph2) & FID-022 (Ph1). Competitive market; strong IP portfolio. $62.6M (22%) revenue from one customer. Facing HRSA audit of $548.9M COVID test reimbursements.
Read full article (5 min)